Pump insulin therapy for diabetes mellitus

Insulin therapy is a pharmaceutical treatment used for patients with diabetes to normalize blood glucose level. In patients receiving insulin therapy, optimization of blood glucose levels can be achieved using various types of insulin and various methods, such as MDI (multiple daily injections) and CSII (continuous subcutaneous insulin infusion). This review describes actual key features of CSII for diabetes patients.

The effect of separate and combined use of t-activin and a-tocopherol on the course of experimental diabetes mellitus

Effects of T-activin and a-tocopherol alone and together on lipid peroxidation (LPO) and carbohydrate metabolism are studied in rats with streptosotocin diabetes (male rats, n=102). Antioxidative activity of T-activin is compatible to that of a.-tocopherol. The antioxidative effect of combined therapy with both agents is more expressed than of monotherapy. T-activin normalized LPO and glycaemic values and increased blood plasma insulin level, which can be regarded as the onset of reparative regeneration of insulin-producing cells; v.-tocopherol did not notably increase the level of insulin or normalize blood glucose level. Thus, T-activin is characterized by a wider spectrum of therapeutic effects in experimental diabetes than a tocopherol.